Zepbound 2.5 MG/0.5 ML pen 0.5ML
Ended Awarded Last action
- Contract number
- SPE2DR26FS25W
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $12,024
Award facts
- Contract value 100% obligated
- $12,023.51 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a $12,023.51 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Zepbound 2.5 mg/0.5 mL pen (0.5 mL), a GLP-1 receptor agonist medication used for weight management. The contract, which is not set-aside, was awarded on January 29, 2026, with an ultimate completion date of January 30, 2026, and will be performed at the awardee's location in Conshohocken, Pennsylvania. This delivery order represents a task order under AmerisourceBergen's parent company Cencora, Inc.'s larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999.00 through December 2031, which serves as the primary vehicle for supplying comprehensive pharmaceutical and medical supplies to support military healthcare programs globally.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, maintains a significant federal contracting presence through its parent organization Cencora, Inc. The company's DLA IDC encompasses an extensive range of medical commodities including specialty medications, brand-name and generic drugs, vaccines, and medical supplies across multiple therapeutic domains. This specific delivery order for Zepbound reflects the company's role in supplying essential pharmaceutical products to military treatment facilities and other federal healthcare systems under a competitively awarded, full and open contracting process.
Quick answers
Who was awarded contract SPE2DR26FS25W?
SPE2DR26FS25W was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 29, 2026.
How much is contract SPE2DR26FS25W worth?
The government has obligated $12,024 on SPE2DR26FS25W.
Is contract SPE2DR26FS25W an order under another contract?
Yes. SPE2DR26FS25W is a delivery order under SPE2DR25D2204, an indefinite delivery contract.
Was contract SPE2DR26FS25W competed?
The extent of competition for SPE2DR26FS25W was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award